379
On 29/10/2007, a new orphan medicinal product was registered into the community register of orphan medicinal products under the EU orphan designation number 490. The active ingredient is Human autologous bone-forming cells derived from bone marrow stem cells for treatment of non-traumatic osteonecrosis.